{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:24:03Z","timestamp":1782969843379,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007914","name":"University of Texas Southwestern Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.cca.2020.12.018","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T11:22:53Z","timestamp":1608636173000},"page":"90-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Circulating macroprolactin exhibits molecular heterogeneity and is not exclusively an antibody complex"],"prefix":"10.1016","volume":"514","author":[{"given":"Khanh","family":"Quynh N. Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel H.","family":"Langevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"McPhaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim A.","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.12.018_b0005","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cca.2020.12.018_b0010","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4158\/EP15938.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology Disease State Clinical Review: Clinical Relevance of Macroprolactin in the Absence or Presence of True Hyperprolactinemia","volume":"21","author":"Samson","year":"2015","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cca.2020.12.018_b0015","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1210\/jc.2004-1600","article-title":"Immunoglobulin G subclasses and prolactin (PRL) isoforms in macroprolactinemia due to anti-PRL autoantibodies","volume":"90","author":"Hattori","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2020.12.018_b0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejogrb.2004.06.020","article-title":"Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!","volume":"118","author":"Gezer","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.cca.2020.12.018_b0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4414\/smw.2001.06127","article-title":"Macroprolactinaemia, the major unknown in the differential diagnosis of hyperprolactinaemia","volume":"131","author":"Cattaneo","year":"2001","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.cca.2020.12.018_b0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2478\/v10011-011-0038-y","article-title":"Detection of Macroprolactinemia and Molecular Characterization of Prolactin Isoforms in Blood Samples of Hyperprolactinemic Women","volume":"31","author":"Chawla","year":"2012","journal-title":"J Med Biochem"},{"key":"10.1016\/j.cca.2020.12.018_b0035","doi-asserted-by":"crossref","first-page":"10384","DOI":"10.1073\/pnas.91.22.10384","article-title":"Mart\u00ednez de la Escalera G. The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin","volume":"91","author":"Clapp","year":"1994","journal-title":"PNAS"},{"key":"10.1016\/j.cca.2020.12.018_b0040","first-page":"44","article-title":"Prolactin and Its 16-kDa N-Terminal Fragment Are Higher in Patients with Precapillary Pulmonary Hypertension than in a Healthy Control Group","volume":"39","author":"Uta H\u00f6nicke","year":"2012","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.cca.2020.12.018_b0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1258\/0004563053857969","article-title":"Macroprolactin; high molecular mass forms of circulating prolactin","volume":"42","author":"Fahie-Wilson","year":"2005","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2020.12.018_b0050","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0002-9378(83)90002-9","article-title":"Prolactin molecular heterogeneity. Response to thyrotropin-releasing hormone stimulation of concanavalin A bound and unbound immunoassayable prolactin during human pregnancy","volume":"147","author":"Shoupe","year":"1983","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2020.12.018_b0055","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/000456329002700604","article-title":"Prolactin and growth hormone: molecular heterogeneity and measurement in serum","volume":"27","author":"Smith","year":"1990","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2020.12.018_b0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2020.12.018_b0065","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1056\/NEJMcp025334","article-title":"Clinical practice","volume":"349","author":"Schlechte","year":"2003","journal-title":"Prolactinoma. N Engl. J. Med."},{"key":"10.1016\/j.cca.2020.12.018_b0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF03348312","article-title":"The management of prolactin-secreting pituitary tumors","volume":"4","author":"George","year":"1981","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.cca.2020.12.018_b0075","first-page":"59","article-title":"Importance of screening for macroprolactin in all hyperprolactinaemic sera","volume":"35","author":"Jamaluddin","year":"2013","journal-title":"Malays. J. Pathol."},{"key":"10.1016\/j.cca.2020.12.018_b0080","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1210\/jc.2004-2234","article-title":"The impact on clinical practice of routine screening for macroprolactin","volume":"90","author":"Gibney","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2020.12.018_b0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2265.2005.02243.x","article-title":"Clinical relevance of macroprolactin","volume":"62","author":"Gibney","year":"2005","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.cca.2020.12.018_b0090","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1373\/49.9.1434","article-title":"In hyperprolactinemia, testing for macroprolactin is essential","volume":"49","author":"Fahie-Wilson","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2020.12.018_b0095","unstructured":"Quest Diagnostics. Macroprolactin (16122X). Accessed 12\/13\/2021. https:\/\/www.questdiagnostics.com\/hcp\/intguide\/EndoMetab\/EndoManual_AtoZ_PDFs\/Macroprolactin.pdf."},{"key":"10.1016\/j.cca.2020.12.018_b0100","unstructured":"Mayo Clinic Laboratories. Macroprolactin , serum (Test ID:MCRPL). Accessed 12\/13\/2021. https:\/\/www.mayocliniclabs.com\/test-catalog\/Clinical+and+Interpretive\/34643."},{"key":"10.1016\/j.cca.2020.12.018_b0105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1258\/acb.2008.007233","article-title":"False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins","volume":"45","author":"Ram","year":"2008","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2020.12.018_b0110","first-page":"617","article-title":"Serum prolactin in human immunodeficiency virus infection","volume":"50","author":"Ram","year":"2004","journal-title":"Clin. Lab."},{"key":"10.1016\/j.cca.2020.12.018_b0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/jcem-71-1-111","article-title":"The proportion of glycosylated prolactin in serum is decreased in hyperprolactinemic states","volume":"71","author":"Hashim","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Pt 1","key":"10.1016\/j.cca.2020.12.018_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/000456329002700102","article-title":"Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states","volume":"27","author":"Smith","year":"1990","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2020.12.018_b0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/00365519509089606","article-title":"Frequency of hyperprolactinaemia due to large molecular weight prolactin (150\u2013170 kD PRL)","volume":"55","author":"Bjoro","year":"1995","journal-title":"Scand. J. Clin. Lab. Invest."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120305866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120305866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:57:31Z","timestamp":1757861851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120305866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":25,"alternative-id":["S0009898120305866"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.12.018","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating macroprolactin exhibits molecular heterogeneity and is not exclusively an antibody complex","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}